|
⚲
|
| Polyremedy Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001329128 |
| Sale | 2009-06-23 ($10.0 M Offered, $8.0 M Sold) |
| Fund | |
| Phone | 6509602404 |
| Address | 2637 Marine Way Mountain View, 94043 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Thomas Rodgers | |
| Charles Liamos | |
| Daniel Eckert | |
| Michael Greeley | |
| Gary Restani | |
| Kevin Connors | |
| Oleg Siniaguine | |
| Jeffrey Jones | |
| Gary Coughlen | |
| Kevin Barrett |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
R1 RCM Holdco Inc.
✚
|
0.0 | |
|
R1 RCM Inc
✚
|
0.0 | |
|
Seedfunders Therapy iQ Fund II a Series of CGF2021 LLC
✚
|
0.0 | |
|
Seegrid Corp
✚
|
0.0 | |
|
Seek Labs, Inc.
✚
|
0.0 | |
|
Seery John
✚
|
0.0 | |
|
Seeton Eric F.
✚
|
0.0 | |
|
OW-0209 Fund I, a series of CapitalX, LP
✚
|
0.0 | |
|
OW-0223 Fund I, a series of Alexander Erikstrup Funds, LP
✚
|
0.0 | |
|
R15-E23-22, a Series of Very Good Ventures Master Partnershi
✚
|
0.0 |